ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2019

Sep 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2019-09-02

Reporting Person: Patel Kinnari (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-02	Stock Option (Right to Buy)	$10.85	A	50000	Acquired	2029-09-02	Common Stock (50000)	Direct

Footnotes

F1: This option represents a right to purchase a total of 50,000 shares of the Issuer's Common Stock, 16,672 of which will become fully vested and exercisable on September 2, 2020, with the remaining 33,328 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.